+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 492 Pages
  • December 2023
  • Region: Global
  • GlobalData
  • ID: 5648240
The Medical Devices sector report, “Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Injectable Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Injectable Drug Delivery Devices are defined as administration of a drug into patient’s blood through a delivery device.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Injectable Drug Delivery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Injectable Drug Delivery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Injectable Drug Delivery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Injectable Drug Delivery Overview
3 Products under Development
3.1 Injectable Drug Delivery - Pipeline Products by Stage of Development
3.2 Injectable Drug Delivery - Pipeline Products by Segment
3.3 Injectable Drug Delivery - Pipeline Products by Territory
3.4 Injectable Drug Delivery - Pipeline Products by Regulatory Path
3.5 Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
3.6 Injectable Drug Delivery - Ongoing Clinical Trials
4 Injectable Drug Delivery - Pipeline Products under Development by Companies
4.1 Injectable Drug Delivery Companies - Pipeline Products by Stage of Development
4.2 Injectable Drug Delivery - Pipeline Products by Stage of Development
5 Injectable Drug Delivery Companies and Product Overview6 Injectable Drug Delivery - Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Injectable Drug Delivery - Pipeline Products by Stage of Development
  • Injectable Drug Delivery - Pipeline Products by Segment
  • Injectable Drug Delivery - Pipeline Products by Territory
  • Injectable Drug Delivery - Pipeline Products by Regulatory Path
  • Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
  • Injectable Drug Delivery - Ongoing Clinical Trials
  • Injectable Drug Delivery Companies - Pipeline Products by Stage of Development
  • Injectable Drug Delivery - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Injectable Drug Delivery - Pipeline Products by Stage of Development
  • Injectable Drug Delivery - Pipeline Products by Segment
  • Injectable Drug Delivery - Pipeline Products by Territory
  • Injectable Drug Delivery - Pipeline Products by Regulatory Path
  • Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
  • Injectable Drug Delivery - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AcelRx Pharmaceuticals Inc
  • Actuated Medical Inc
  • Adalvo
  • AdrenaCard, Inc.
  • AktiVax Inc.
  • Alexion Pharmaceuticals Inc
  • Allergan Ltd
  • Alsensa ApS
  • Alvotech Swiss AG
  • Amneal Pharmaceuticals Inc
  • Antares Pharma Inc
  • Apellis Pharmaceuticals Inc
  • ApiJect Systems Corp
  • Aptissen SA
  • Aquavit Pharmaceuticals Inc
  • Artemes Technologies, Inc.
  • Ascendis Pharma AS
  • ASCIL Biopharm
  • Ash Access Technology Inc
  • ASIS Corp
  • Auckland Bioengineering Institute
  • AzureBio SL
  • Becton Dickinson and Co
  • Bespak Europe Ltd
  • Biocorp Production SA
  • BioCorRx Inc
  • Biorchestra Co Ltd
  • BioRestorative Therapies Inc
  • Bioxis Pharmaceuticals
  • BoneSupport AB
  • Brigham and Women's Hospital
  • Brixton Biosciences Inc
  • Burke Pharmaceuticals LLC
  • Calla Health Foundation
  • Cambridge Consultants Ltd
  • Camurus AB
  • Carmot Therapeutics Inc
  • Case Western Reserve University
  • Cincinnati Children's Hospital Medical Center
  • Clearside BioMedical Inc
  • Coherus BioSciences Inc
  • Copernicus Sp zoo
  • CrossCoat Medical LLC
  • Crossject SA
  • CSL Behring LLC
  • Curer Inc
  • DALI Medical Devices Ltd.
  • DelSite, Inc. (Inactive)
  • DelSiTech Ltd
  • Department of Biomedical Engineering Columbia University
  • Difinity Solutions
  • Drexel University
  • Duoject Medical Systems Inc
  • E3D Elcam Drug Delivery Devices
  • Ebenroth BV
  • Ecole Polytechnique Federale de Lausanne
  • EmboMedics Inc
  • Embryyo Technologies Pvt Ltd
  • Emergent BioSolutions Inc
  • EP Global Communications Inc (Inactive)
  • EpicentRx Inc
  • Establishment Labs SA
  • Eveon SAS
  • EyeCool Therapeutics Inc
  • EyePoint Pharmaceuticals Inc
  • F. Hoffmann-La Roche Ltd
  • FHC Inc
  • FluGen Inc
  • Fresenius Kabi AG
  • GeneSYS-ID Inc
  • Georgia Institute of Technology
  • Ghent University
  • Globe Medical Tech Inc (Inactive)
  • Halozyme Therapeutics Inc
  • Hillmed Inc
  • Ichor Medical Systems Inc
  • Immunovant Inc
  • Impulse Biomedical
  • Inovio Pharmaceuticals Inc
  • InVivo Therapeutics Corp
  • iScience Interventional Inc
  • JCR Pharmaceuticals Co Ltd
  • Johns Hopkins University
  • LG Chem Ltd
  • Liposphere Ltd
  • Love Lifesciences LLC
  • LyoGo
  • Mallinckrodt Plc
  • Medovate Ltd
  • Mercator MedSystems Inc
  • Mertiva AB
  • Milestone Scientific Inc
  • Mingche Biotechnology (Suzhou) Co Ltd
  • Monash University
  • Morimoto Pharma Co Ltd
  • NanoSyrinx Ltd
  • Nemera La Verpilliere
  • Nipro Corp
  • Nordic Group BV
  • Northwestern University
  • Nota Laboratories LLC
  • NovaXS Biotech Corp.
  • Novo Nordisk AS
  • Novosanis NV
  • NuvOx Pharma LLC
  • Ocular Therapeutix Inc
  • Ohio State University
  • Old Dominion University
  • Osteo Pharma BV
  • Oval Medical Technologies Ltd
  • Owen Mumford Ltd
  • Palatin Technologies Inc
  • Palette Life Sciences AB
  • Particle Therapeutics Ltd
  • Pennsylvania State University
  • Pfizer Inc
  • Pharmosa Biopharm Inc
  • Portal Instruments Inc
  • Prohibix LLC
  • Purdue Pharma LP
  • Purdue University
  • Pykus Therapeutics Inc
  • QuiO Technologies LLC
  • Rebel Medicine Corp
  • Recon Therapeutics, LLC
  • Regeneron Pharmaceuticals Inc
  • Renovos Biologics Ltd
  • RepliCel Life Sciences Inc
  • Rescitech Vision Pvt Ltd
  • RetinaPharma Technologies Inc
  • Re-Vana Therapeutics Ltd
  • Roche Pharma AG
  • SafePush LLC
  • Sapporo Medical University School of Medicine
  • Schott AG
  • Shanghai Weimu Medical Technology Co Ltd
  • SHL Medical USA LLC
  • Singapore Eye Research Institute
  • Societe Industrielle De Sonceboz SA
  • Sorrento Therapeutics Inc
  • Southern Medical University
  • Southwest Research Institute
  • Spinal Restoration Inc (Inactive)
  • Stevanato Group SpA
  • Subcuject ApS
  • Sunshine Guojian Pharmaceutical Shanghai Co Ltd
  • SURGE Therapeutics Inc
  • Takeda Pharmaceutical Co Ltd
  • TCB medical devices
  • Tempest Therapeutics Inc
  • Terumo Corp
  • Teva Pharmaceutical Industries Ltd
  • Teva Pharmaceuticals USA Inc
  • TheraKine Inc (Inactive)
  • Twin Star Medical Inc
  • Unilife Corporation
  • University College London
  • University of Calgary
  • University of California San Diego
  • University of California San Francisco
  • University of Connecticut Health Center
  • University of Delaware
  • University of Dundee
  • University of Florida
  • University of Galway
  • University of Michigan
  • University of New Mexico
  • University of Saskatchewan
  • University of South Florida
  • University of Texas at Austin
  • University of Texas at San Antonio
  • University of Texas Health Science Center at Houston
  • University of Texas Rio Grande Valley
  • University of Utah
  • Vanderbilt University
  • West Pharmaceutical Services Inc
  • Windgap Medical Inc
  • Wuhan Tianshiwei Holdings Co Ltd
  • Xeris Biopharma Holdings Inc
  • Ypsomed Holding AG
  • Zealand Pharma AS
  • ZebraSci Inc
  • Zosano Pharma Corp